• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology

    2020-06-29 07:57:02YuLiangZhangQianCuiDouZhangXinMaGuoWeiZhang
    Traditional Medicine Research 2020年4期

    Yu-Liang Zhang, Qian Cui, Dou Zhang, Xin Ma, Guo-Wei Zhang*

    Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology

    Yu-Liang Zhang1, Qian Cui1, Dou Zhang1, Xin Ma1, Guo-Wei Zhang1*

    1College of Traditional Chinese Medicine, Hebei University, Baoding 071000, China.

    : To evaluate the mechanism of Chinese patent drug Xuebijing (XBJ) injection in the treatment of a new coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking technology.: The TCMSP database was employed to collect and screen the active ingredients of the Chinese herb contained in the XBJ injection. The GeneCards database and STRING database were applied to collect and expand the targets of COVID-19 and compare and screen the related targets of COVID-19 by XBJ injection. Cytoscape was employed to build a network connecting Chinese medicine, compounds, targets, disease, and topology analysis was performed via the Network Analyzer to screen the key ingredients and targets. The software of Schr?dinger molecular docking was used to verify the binding activity of the key ingredients of XBJ injection and the key targets of COVID-19. Metascape platform and DAVID database were utilized to conduct Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes analysis on the key targets of COVID-19 treated by XBJ injection.Eight key compounds and 15 key targets were screened and verified by molecular docking; these key compounds included luteolin, quercetin, baicalein, and kaempferol. The key targets included DPP4, AR, ESR1, CALM1, and protein kinase 1. Gene Ontology analysis involved an apoptosis and hypoxia reaction and the changes in blood vessel morphology. Kyoto Encyclopedia of Genes and Genomes analysis involved signaling pathways of hypoxia inducible factor-1, VEGF, and PI3K/AKT/NF-κB.: The mechanism of XBJ injection when used to treat COVID-19 should be further investigated as the key compounds in XBJ regulated the expression of key targets such as protein kinase 1, VEGF-A, B-cell lymphoma-2, and TNF, which affected the COVID-19 receptors such as angiotensin-converting enzyme 2 and signaling pathways like hypoxia inducible factor-1, PI3K-Akt, and NF-κB, which alleviated the inflammation, respiratory distress, and hypoxia caused by COVID-19 infection.

    Network pharmacology, Molecular docking, COVID-19, Xuebijing injection, Luteolin, Quercetin

    The Chinese drug formula Xuebijing (XBJ) injection ameliorated the inflammatory reaction, respiratory distress, and hypoxia caused by coronavirus disease 2019 infection. Its underlying mechanism is via affecting the angiotensin-converting enzyme 2 and signaling pathways of hypoxia inducible factor-1, PI3K-Akt, and NF-κB by regulating the expression of protein kinase 1, VEGF-A, B-cell lymphoma-2, TNF, and other targets.

    The prescription of XBJ injection was first introduced in the Xuefu Zhuyu decoction in the medical book Yilin Gaicuo (), written by Wang Qingren, a famous Chinese physician in the 1830s of the Qing Dynasty of China. The decoction is composed of such main ingredients as Honghua (),Chishao (),Chuanxiong (), Danshen ()and Danggui () with glucose as an auxiliary material that can clear away heat and toxic material (equivalent to an anti-inflammatory effect in Western medicine). XBJ injection has obtained the production approval of the State Food and Drug Administration of China and a new drug certificate for the drug of second class (approval number: Z20040033) in 2004. It has been employed for the clinical treatment of pneumonia for more than ten years, primarily as a treatment for severe pneumonia and severe pneumonia with sepsis, respiratory distress, respiratory failure, and fever with profound effects. It was designated as a severe drug in the(trial version 7) and obtained an approval letter of supplementary application by the State Food and Drug Administration of China for use as an additional drug application for new indications including severe pneumonia, critical systemic inflammatory response syndrome, or multiple organ failure from the novel coronavirus.

    Background

    A new coronavirus disease 2019 (COVID-19) occurred in Wuhan, Hubei Province, China, in December of 2019, which quickly spread to other countries. The fast sprawl of this epidemic and the potentially deadly respiratory symptoms of this disease have created a global public health hazard of pandemic proportions [1, 2]. Coronaviruses are species of virus in the family Coronaviridae, which are associated with common colds and significantly more serious diseases such as Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome [3]. The new coronavirus belongs to a new strain that has never been found in the human body before. No targeted, effective drug, primarily aimed at the symptomatic treatment of COVID-19, is currently available. Thus, the formulation of a plan for the rapid and effective treatment of this disease is an overarching problem [4].

    Traditional Chinese medicine (TCM) has proved to be useful for viral pneumonia treatment and has shown favorable efficacy in the treatment of the Severe Acute Respiratory Syndrome outbreak in 2003. The treatment of COVID-19 with TCM is one of the vital treatment protocols in theissued and continuously updated by the National Health Commission of China. The prescription of Xuebijing (XBJ) injection came from the Xuefu Zhuyu decoction in the medical book Yilin Gaicuo (), written by Wang Qingren, a famous Chinese physician in the 1830s of the Qing Dynasty of China. The decoction is composed of Honghua (),Chishao (),Chuanxiong (), Danshen ()and Danggui () with glucose as an auxiliary material and is associated with clearing away heat and toxic material (equivalent to an anti-inflammatory effect in Western medicine). XBJ injection has obtained production approval from the State Food and Drug Administration of China and a new drug certificate as a drug of second class (approval number: Z20040033) in 2004. It has been employed for the clinical treatment of pneumonia for more than ten years, primarily for severe pneumonia, severe pneumonia with sepsis, respiratory distress, respiratory failure, and fever with profound effects [5]. It was designated as a severe drug in the(trial version 7) and has obtained an approval letter for the supplementary application by the State Food and Drug Administration of China for an additional drug application for newer indications such as severe pneumonia, critical systemic inflammatory response syndrome, or multiple organ failure caused by the novel coronavirus [6].

    Analysis of the multiple ingredients and targets can be conducted via network pharmacology, a holistic approach used to explore the potential effects of the drugs on diseases [7]. Furthermore, this research method coincided with the overall concept of the TCM treatment of diseases, placing a bedrock for research into the mechanism of action of TCM. Molecular docking is a method of designing drug molecules through computer-aided means. By simulating the geometric structure of the molecules and the intermolecular forces, it can be used to predict the interaction between drugs and targets and can screen the effects of the active ingredients of TCM quickly and accurately, which has played a paramount role in the study of the mechanism of the effects of drugs [8].

    This study analyzed the potential mechanism of XBJ’s treatment in COVID-19 through multiple targets, channels, and pathways by network pharmacology and molecular docking. The research flow chart is shown in Figure 1.

    Figure 1 Flow chart of this study

    Material and methods

    Screening of effective compound ingredients and the targets of XBJ injection

    Candidate active compounds and targets were ultimately acquired via screening conditions by using TCMSP (http://tcmspw.com/tcmsp.php) [9] database to search the XBJ related active ingredients with oral bioavailability ≥ 30% according to the parameters of the human body absorption distribution metabolism and drug-likeness ≥ 0.18.

    Prediction of the potential therapeutic targets of COVID-19

    Based on the GeneCards [10] database with “coronavirus disease 2019” as a keyword, the related disease targets were collected and screened with a relevance score > 20 and then the target proteins related to COVID-19 were expanded by the STRING (https://string-db.org/) database [11]. The protein-protein interactions included in the STRING database could adequately reflect which proteins conducted the interaction. With the medium confidence set to 0.400 and the limitation of species as “Homo sapiens”, the targets expanded thereafter were the ones that interacted with the known target of COVID-19, which was capable of being used as a potential therapeutic target of COVID-19.

    Screening of the related targets for XBJ injection in the treatment of COVID-19

    The collected targets of XBJ were compared with the potential therapeutic targets of COVID-19 through the graphics option in TB tools to find the intersection of tow targets as the potential target, and then the Venn diagram of the collection of the injection targets of XBJ and the COVID-19-related targets were drawn to collect the intersection of the target genes, which were the targets in the XBJ treatment of COVID-19. Finally, the gene symbols of the related targets were mapped to UniProt ID through the UniProt (https://www.uniprot.org/) database.

    Screening of the key targets and key compounds involved in XBJ treatment of COVID-19

    In order to further screen the key compounds and key targets, the related targets of COVID-19 were treated with XBJ injection and were mapped to the corresponding chemical ingredients, and Cytoscape 3.7.2 [12] was applied to construct a herb-compound-targets-disease network to visualize this relationship. Subsequently, the key ingredients and key targets were screened via a topology analysis of the network performed by Network Analyzer.

    Verification of the binding activity of the key ingredients of XBJ injection and the key targets of COVID-19 by molecular docking

    The 3D structure of the compound in the mol2 format was obtained in the Pubchem (https://pubchem.ncbi.nlm.nih.gov/). Then, searched and screened for the target protein in the Protein Data Bank (PDB) database (https://www.rcsb.org/). The Ligand Docking module of Schr?dinger was used for molecular docking. The PDB database stores structural data such as molecular crystallography, nuclear paramagnetic resonance spectroscopy, and 3D electron microscopy [13]. Screening conditions of this protein were as follows: (1) the analysis method was single-crystal X-ray diffraction; (2) resolution < 2A; (3) time of discovery was as late as possible; (4) preference was given to those containing small molecule ligands, of which angiotensin-converting enzyme 2 (ACE2) was currently selected due to the smaller database structure, and the conditions did not include resolution. Then, pretreatment of the compounds and proteins before docking involved the following the small molecule ligand was docked based on the active site of the small molecule ligand, and those without were docked with the active site calculated by using the binding site detect function of the Schr?dinger software. The docking precision was set to standard precision, and the reference was the original ligand and ACE2, a known target of COVID-19. The results of the molecular docking and scoring were drawn as a heat map, and the binding mode was analyzed to verify the degree of binding of the key ingredients of XBJ injection to the key targets of COVID-19.

    Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of key targets

    The GO annotated gene targets the following three aspects: cellular components, molecular function, and biological processes. KEGG pathway analysis was used to comprehend the advanced functions and applications of the biological systems from the perspective of the molecular level. In order to explore the mechanism of XBJ treatment of COVID-19, GO annotation analysis was carried out via Metascape (https://metascape.org/) [14] platform using the UniProt ID of the key target. The threshold was< 0.01 and minimum count3, enrichment factor > 1.5; KEGG pathway analysis was created by the UniProt ID of key targets in the DAVID (https://david.ncifcrf.gov/) [15] database. Cytoscape 3.7.2 was used to construct the ingredients-targets-GO-KEGG (I-T-G-K) diagram for the results of the analysis.

    Results

    Active ingredients and targets of XBJ injection

    The TCMSP database was applied, removing the sterol vitamins and sugars shared in the plants and vitamins, 115 effective compounds of XBJ were obtained, including 19 of Honghua (), 25 of Chishao (), 6 of Chuanxiong (), 65 of Danshen () and none of Danggui (). Among them, there are 411 predicted targets of Honghua (), 275 of Chishao (), 72 of Chuanxiong (), 197 of Danshen ()Five hundred thirty predicted targets of XBJ were obtained after removing the duplicates.

    Prediction of the potential therapeutic targets of COVID-19

    The COVID-19-related disease targets collected using the GeneCards database are shown in Figure 2 after the STRING database is expanded. The red nodes in the central area collected 24 targets for the GeneCards database, and the purple nodes in the outer circle expanded the STRING database. A total of 218 related disease targets were collected following expansion.

    Screening of the related targets during XBJ treatment of COVID-19

    The Venn diagram is a comparison between the COVID-19 potential therapeutic targets expanded, and the XBJ target and is depicted in Figure 3. A total of 44 intersection targets were visible, which are shown in Table 1. It has been suggested that these targets might be related to the targets for XBJ treatment of COVID-19. The intersection targets of the drug and the target of the disease do not include the currently found targets related to coronavirus infection, such as ACE2, which indicates that XBJ injection may not directly act on the ACE2 protein, and maybe an indirect relationship exists between them.

    Figure 2 Network of expanding targets. The red nodes collect 24 targets for the GeneCards database, and the purple nodes expand the STRING database.

    Figure 3 Venn diagram of coincidence targets

    Table 1 Targets of COVID-19

    Key targets and compounds of the XBJ treatment for COVID-19

    The related targets of XBJ injection treatment of COVID-19 were mapped to the corresponding chemical ingredients, and Cytoscape was applied to construct a network diagram of the herb-compound-target-disease, as depicted in Figure 4. In order to further screen the key compounds and targets, Network Analyzer was employed to perform a topological analysis on the network in Figure 4 to obtain three network topology parameters such as degree centrality, betweenness centrality (BC), and closeness centrality (CC). The screening was based on parameters twice than the median [16], and eight key compounds were selected, as shown in Table 2. 15 key targets were selected, and the related characteristics are shown in Table 3. It has been suggested that XBJ treatment of COVID-19 might involve such compounds as luteolin, quercetin, baicalein, kaempferol, and others acting on the key target proteins like dipeptidyl peptidase-4 (DPP4), AR, ESR1, CALM1, protein kinase 1 (AKT1), of which DPP4, TP53, TNF, CASP3, and NOS3 were the targets without expanding protein-protein interactions, which played a significant role in the treatment.

    The verification of the binding activity of the XBJ key compounds and the COVID-19 key targets via molecular docking

    Molecular docking using Schr?dinger software verified whether the strong binding activity is between the smaller molecular compounds and the target. Protein Data Bank-identification (ID), Ligand-ID and resolution can all be seen in Table 4. A component-target docking score of less than 0 indicated a successful docking, the higher the absolute value of the score, the tighter the binding [17]. The fact that the score of the docking compound is close to the original ligand proves that the compound plays a significant role in determining the targets during treatment. The heat map of the molecular docking results is depicted in Figure 5. The depth of the color represents the docking score. The comparison of the scores of the key targets and the positive control ACE2 to the original ligand demonstrated that each key compound exhibited effective binding activity with at least 8 COVID-19 key targets. This result proved that the XBJ key compound performed binding activity to the COVID-19 key targets.

    Through a detailed analysis of the image of the molecular docking result, the small molecule could be tightly bound to the active site of the target protein. In order to show a link between the target protein and the small molecules through a variety of chemical bonds, this is the typical binding model involved in the relevant chemical bond in the selection. In this paper, the combination mode of ellagic acid (MOL001002) docking ACE2, quercetin (MOL000098) docking DPP4, luteolin (MOL000006) docking ATK1, and baicalein (MOL002714) docking B-cell lymphoma-2 (BCL2) are depicted in Figure 6. From the overall diagram on the left, the small molecule compounds could bind tightly to the active sites of the receptor proteins. Small molecules were interlocked through their hydrogen bonds, salt bridge, and pi-pi interactions (Figure 6). The salt bridge exhibited by the purple dotted line is the most common force between the proteins, and the effect of binding on the two atomic groups together is due to a strong electrostatic interaction between the positive and negative charges. This force is weaker than the hydrogen bonds; however, it has a significant influence on the overall stability of the combination as it is found in large amounts [18]. The pi-pi stacking showed by the red dotted line tends to occur in the weak interactions between the electron-rich aromatic ring and the electron-deficient aromatic ring. To a large extent, it affects the reliability of the combination [19]. The hydrogen bond of the yellow dotted line is a kind of intermolecular force between the permanent dipoles. Hydrogen bonds occurred between a hydrogen atom bound to other atoms by covalent bonds, which result in another atom afforded a more substantial binding capacity second only to the covalent bond. Hydrogen bonds are the primary determinant as to whether the small molecules could bind to the target protein or not [20].

    Figure 4 Herb-compounds-targets-disease network. The blue bold text is the target before expansion.

    Table 2 Related characteristics of the key compounds

    BC, betweenness centrality; CC, closeness centrality.

    Table 3 Related characteristics of key targets

    ID, identification; BC, betweenness centrality; CC, closeness centrality.

    Table 4 Information on 15 proteins involved in molecular docking

    PDB, Protein Data Bank; ID, identification;–, not mentioned.

    Figure 5 Heat map for docking score. The depth of color represents the docking score; a docking score of less than 0 indicates a successful docking, the higher the absolute value of the score, the tighter the binding.

    Analysis of the GO biological process and the KEGG pathway for the key targets

    GO biological process analysis. GO biological process analysis obtained a total of 172 enrichment pathways, including 33 pathways related to COVID-19. It selected the 20 GO terms with the smallest-value to display in a graphical table (Figure 7). In Figure 7, the ordinate is a GO term, and the abscissa is the percentage of the target gene count of the GO term to the total count of the target genes, the darker the color, the smaller the-value. The value of the column was the count of the genes in a GO term.

    A. ACE2 and MOL001002B. DPP4 and MOL000098 C. ATK1 and MOL000006D. BCL2 and MOL002714

    Figure 6 Binding modes of targets and compounds. The purple dotted line is the salt bridge, the red dotted line is pi-pi stacking, and the yellow dotted line is the hydrogen bond. ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; AKT1, protein kinase 1; BCL2, B-cell lymphoma-2.

    Figure 7 Enrichment analysis of the GO biological process. The ordinate is a GO term and the abscissa is the percentage of the target gene count of the GO term to the count of all of the target genes. The color represents the-value, the darker the color, the smaller the-value. The value of the column is the count of genes in a GO term.

    The biological processes indicated that the treatment of COVID-19 by XBJ involved apoptosis, response to hypoxia, blood vessel morphogenesis, regulation of macroautophagy, and response to TNF. This result shows that XBJ can affect these biological processes in the treatment of diseases.

    KEGG pathway analysis. KEGG pathway enrichment obtained a total of 57 enriched pathways, of which 27 pathways were related to COVID-19. The 20 KEGG pathways with the smallest-value are depicted in the graphical display (Figure 8). The Y-axis represents the pathway name, the X-axis represents the enrichment degree, and the air bubble size indicates the number of targets contained in the pathway, the color of the significance of the pathway, is correlated to the data of the-value.

    The KEGG pathway analysis results showed that the XBJ treatment of COVID-19 involved the signaling pathways of hypoxia inducible factor-1 (HIF-1), TNF, NF-κB, VEGF, PI3K-Akt, and p53. It illustrated that the active ingredients of XBJ might be able to treat diseases via influencing these signaling pathways.

    The construction of the ingredients-targets-diseases-pathway relationship. In order to organize the I-T-G-K relationship, Cytoscape 3.7.2 was used to construct the I-T-G-K relationship diagram. The nodes with different colors and shapes represent the corresponding diseases, ingredients, and targets (Figure 9). The 15 key targets of XBJ were distributed in distinct metabolic pathways and biological processes which jointly regulated the organismal level. The targets reflected the mechanism of action involved in this multi-component TCM, which suggested potential as a multi-targeted therapy to treat COVID-19.

    Figure 8 Enrichment analysis of the KEGG pathway. The Y-axis represents the pathway name, and the X-axis represents the enrichment degree; the air bubble size indicates the number of targets contained in the pathway and the color shows the data of the-value of the pathway.

    Figure 9 I-T-G-K network. I-T-G-K, ingredients-targets-GO-KEGG; KEGG, Kyoto Encyclopedia of Genes and Genomes.

    Discussion

    XBJ has been used as a specific, clinical, and evidence-based treatment of pneumonia for more than a decade. It is mostly used in severe pneumonia and severe pneumonia complicated with sepsis, respiratory distress, and respiratory failure, and fever [21]. Therefore, it has become a Chinese patent medicine as a joint recommendation for use as a therapy for both Chinese medicine and Western medicine and has been proven to be effective in improving community-acquired pneumonia outcomes [22]. Severe COVID-19 patients will experience symptoms such as acute respiratory distress syndrome, fibrosis of the lungs, septic shock, metabolic acidosis, and blood coagulation dysfunction. Therefore, the optimal treatment for severe patients should improve pulmonary function and hypoxia, reduce acute lung injury, pulmonary fibrosis, and enhance the antiviral immune response to reduce inflammation and other aspects [23, 24]. Therefore, the current study was based on research to determine a multi-component and multi-targeted therapy for COVID-19. Through network pharmacology technology and molecular docking technology, this study explored the potential targets of XBJ treatment for COVID-19 and stated the mechanism of action found to provide a scientific basis for clinical application. Our specific findings are as follows.

    The analysis results of the XBJ treatment for the COVID-19 key targets and key compounds showed that eight key compounds regulated 15 key targets. Among the key compounds found in XBJ, the flavonoids accounted for the majority including luteolin (MOL000006), quercetin (MOL000098), baicalein (MOL002714), tanshinone iia (MOL007154), myricanone (MOL002135); then the phenols such as ellagic acid (MOL001002), kaempferol (MOL000422); and the quinone dan-shexinkum d (MOL007093). Flavonoids such as baicalein inhibit the inflammatory factors such as TNF and interleukin (IL) by interfering with the NF-κB pathway, which exert antipyretic and anti-inflammatory effects, inhibit inflammation and apoptosis, and reduce acute lung injury [25]. Quercetin reduces the production of NF-κB and ICAM-1 by inhibiting the NF-κB signaling pathway and achieves anti-inflammatory effects [26]; reportedly, it could improve lung fibrosis in murine models by inhibiting the SphK1/S1P signal transduction [27]. Phenolic compounds such as ellagic acid has anti-inflammatory, anti-allergic, antiviral, and anti-cancer properties. It is reported that ellagic acid inhibits the Akt, ERK, p38, MAPK, and PI3K/Akt pathways, and the NF-κB anti-inflammatory signaling pathways to trigger anti-inflammatory effects [28].

    Key targets included DPP4, AR, ESR1, CALM1, AKT1, CASP3, NOS3, VEGF-A, TP53, BCL2, TNF, JUN, CDKN1A, FOS and BAX. The results of molecular docking suggest that the above targets and ACE2 could effectively bind to the compound. AKT1 is a direct target downstream of the PI3K pathway and regulated many processes, including proliferation, apoptosis, inflammation, and angiogenesis [29]. The literature shows that AKT1 could regulate apoptotic resistance and pulmonary fibrosis by mediating the mitochondria [30]. BCL2 is a protein with inhibitory effects on apoptosis, through the interaction between proteins, and regulats the permeability of the outer mitochondrial membrane, thereby it controlls mitochondrial autophagy and affects apoptosis [31]. Other literature reports that in fibroid lungs and activated fibroblasts, regulating the expression of BCL2 and autophagy activity could be adjusted to reduce autophagy, which plays a role in inhibiting pulmonary fibrosis [32]. TP53 is a transcription factor, and transcriptional activation functioned to maintain the stability of the genome and plays multiple roles in apoptosis, including differentiation, aging, DNA repair, metabolism, and the immune response [33]. Another study has demonstrated that promoting the expression of TP53 could induce the secretion of the WNT ligands, stimulate tumor-associated macrophages to produce IL-1β, and inhibit the subsequent neutrophil inflammation [34]. Therefore, it might play a similar role in the pathogenesis of COVID-19. VEGF-A, a vascular regulator, plays a vital role in promoting angiogenesis, endothelial cell migration, and proliferation [35, 36]. Furthermore, ACE2 reportedly antagonized the increase in pulmonary vascular permeability mediated by VEGF-A and thereby improved pulmonary function following an acute lung injury [39]. Since ACE2 is considered as a viral receptor of COVID-19 [38–40], XBJ might affect the expression of the ACE2 receptors by influencing the VEGF-A enough to treat this disease.

    Based on the analysis of the Go biological process, this article found that the relevant biological processes involved in XBJ as a potential treatment of COVID-19 primarily included apoptosis, response to hypoxia, blood vessel morphogenesis, regulation of macroautophagy, and the response to TNF. These processes might have regulated the mechanism of generation and development of COVID-19. The generation process of COVID-19 includes pulmonary injury and lung fibrosis, inflammation, and hypoxia. XBJ restored the impaired blood vessels and ameliorated hypoxia by interfering with macroautophagy and relieving inflammation. The analysis of the I-T-G-K network suggested that XBJ could treat COVID-19 by acting on multiple pathways.

    The HIF-1 signaling pathway is crucial for an organism during a low oxygen concentration and hypoxia response [41]. HIF-1 regulates hundreds of gene transcriptions in the expression of cell-specific, including VEGF-A, IL6, AKT1, and NF-κB [42]. Under hypoxia, the HIF-1 signaling pathway activates the VEGF signaling pathway, which could be protective by up-regulating the reverse transcription of VEGF, and inflammation could be relieved by regulating IL6, TNK, AKT1, and NF-κB [43]. Thus, XBJ might improve pulmonary injury, restore impaired vessels, and hypoxia by affecting HIF-1 and VEGF.

    NF-κB signaling pathway is found to be crucial to the inflammation and immune response of cells [44]. NF-κB pathway reportedly inhibits replication of the influenza a virus and exacerbates viral pneumonia [45, 46]. TNF, AKT1, and NF-κB are closely related to the PI3K-Akt signaling pathway and NF-kappaB signaling pathway. PI3K-Akt activates NF-κB to regulate many aspects, such as anti-inflammation-related to multiple cellular gene expressions [46]. In the development of cancer, NF-κB plays a vital role in regulation. Reportedly, lower transcription activity by NF-κB decreases expression of the inflammatory cytokines such as IL-1β, TNF-α, and IL-6; thus, reducing inflammation and apoptosis as well as alleviating pulmonary injury [47]. In vitro, TNF-α-induced acute lung injury could be attenuated via inhibiting NF-κB and activating Nrf2 [48]. Moreover, in vivo animal experiments found the release of proinflammatory cytokines-was mediated by PI3K/AKT/GSK3β and NF-κB [49]. Therefore, XBJ might have an anti-inflammatory effect by affecting the activation of PI3K/AKT/NF-κB, which could reduce inflammation caused by COVID-19.

    Conclusion

    Currently, no golden standard exists for the treatment of COVID-19. TCM plays a significant role in treating new diseases because it features multiple ingredients, targets, and approaches. These features were used to explore the complicated mechanism of XBJ in the treatment of COVID-19 via network pharmacology and molecular docking. The mechanism of action showed potential for the key compounds in XBJ, as they regulated the expression of key targets such as AKT1, VEGF-A, BCL2, and TNF, which affected the COVID-19 viral receptors such as ACE2 and the signaling pathways like HIF-1, PI3K-Akt, and NF-κB. Thus, XBJ might take effect by (1) affecting the key targets, and flavonoids in XBJ that attenuated acute lung injury by alleviating the inflammation and apoptosis; (2) affecting VEGF-A and then the expression of the ACE2 receptor; (3) activating VEGF by affecting HIF-1, which improved pulmonary injury, restored the impaired vessels, and hypoxia; (4) alleviating the inflammation caused by COVID-19 by activating PI3K/AKT/NF-κB.

    At present, the pathogenesis of COVID-19 has not yet been elucidated. Thus, the mechanism of XBJ involved in the treatment of COVID-19 requires further research. The current study reflects the holistic and systematic characteristics of TCM treatment by studying the interactions between these therapeutic targets and pathways. This article has provided a basis for exploring the mechanism of XBJ in the treatment of COVID-19 and offers insight into the potential of XBJ for future researchers.

    1. Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020, 91: 264–266.

    2. Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet 2020, 395: 542–545.

    3. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med 2020.

    4. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov, 2020, 19: 149–150.

    5. Liu S, Yao C, Zhang J, et al. Efficacy of Xuebijing injection for sepsis (EXIT-SEP): protocol for a randomised controlled trial. BMJ Open 2019, 9: e28664.

    6. Scheme for diagnosis and treatment of 2019 novel coronavirus pneumonia (The 7th Trial Edition). Jiangsu Journal of Traditional Chinese Medicine 2020, 52: 1–6. (Chinese)

    7. Boezio B, Audouze K, Ducrot P, et al. Network-based approaches in pharmacology. Mol Inform 2017, 36.

    8. Saikia S, Bordoloi M. Molecular docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets 2019, 20: 501–521.

    9. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014, 6: 13.

    10. Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 2016, 54: 1–30.

    11. Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019, 47(D1): D607–D613.

    12. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13: 2498–2504.

    13. Burley SK, Berman HM, Bhikadiya C, et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res 2019, 47(D1): D464–D474.

    14. Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019, 10: 1523.

    15. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37: 1–13.

    16. Cui Q, Zhang YL, Ma YH, et al. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke. J Ethnopharmacol 2020: 112891.

    17. Etti I, Abdullah R, Hashim NM, et al. Artonin E and structural analogs from Artocarpus species abrogate estrogen receptor signaling in breast cancer. Molecules 2016, 21.

    18. Zhang N, Wang Y, An L, et al. Entropy drives the formation of salt bridges in the protein GB3. Angew Chem Int Ed Engl 2017, 56: 7601–7604.

    19. Zhuang W, Wang Y, Cui P, et al. Applications of pi-pi stacking interactions in the design of drug-deliverysystems. J Control Release 2019, 294: 311–326.

    20. Arunan E, Mani D. Dynamics of the chemical bond: inter- and intra-molecular hydrogen bond. Faraday Discuss 2015, 177: 51–64.

    21. Li C, Wang P, Zhang L, et al. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: a meta-analysis of randomized controlled trials. J Ethnopharmacol 2018, 224: 512–521.

    22. Song Y, Yao C, Yao Y, et al. Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med 2019, 47: e735–e743.

    23. Guan WJ, Zhong NS. Clinical characteristics of COVID-19 in China. N Engl J Med 2020, 382.

    24. Jiang F, Deng L, Zhang L, et al. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020.

    25. Chu L, Zhu F, Zhou W, et al. Baicalein attenuates acute lung injury induced by intestinal ischemia/reperfusion via inhibition of nuclear factor-kappaB pathway in mice. Chin Crit Care Med 2017, 29: 228–232. (Chinese)

    26. Liu Y, Yu C, Ji K, et al. Quercetin reduces TNF-alpha-induced mesangial cell proliferation and inhibits PTX3 production: involvement of NF-kappaB signaling pathway. Phytother Res 2019, 33: 2401–2408.

    27. Zhang X, Cai Y, Zhang W, et al. Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1/S1P signaling. Biochem Cell Biol 2018, 96: 742–751.

    28. Kowshik J, Giri H, Kishore TKK, et al. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model. Anticancer Agents Med Chem 2014, 14: 1249–1260.

    29. Rafalski VA, Brunet A. Energy metabolism in adult neural stem cell fate. Prog Neurobiol 2011, 93: 182–203.

    30. Larson-Casey JL, Deshane JS, Ryan AJ, et al. Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis. Immunity 2016, 44: 582–596.

    31. Dai H, Meng W, Kaufmann S. BCL2 family, mitochondrial apoptosis, and beyond. Cancer Transl Med 2016, 2: 7.

    32. Han R, Ji X, Rong R, et al. MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2. J Mol Med 2016, 94: 1267–1279.

    33. Kung C, Basu S, Murphy ME. A link between TP53 polymorphisms and metabolism. Mol Cell Oncol 2016, 3: e1173769.

    34. Delbridge ARD, Kueh AJ, Ke F, et al. Loss of p53 causes stochastic aberrant X-chromosome inactivation and female-specific neural tube defects. Cell Rep 2019, 27: 442–454.

    35. Li T, Jiang Y, Hu Y, et al. Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer. Clin Cancer Res 2017, 23: 1575–1585.

    36. Asensio-Sanchez VM. VEGF-A and VEGF-Ax: bad protein and good protein. Arch Soc Esp Oftalmol 2015: 90, 149–150.

    37. Yu X, Lin Q, Qin X, et al. ACE2 antagonizes VEGF-A to reduce vascular permeability during acute lung injury. Cell Physiol Biochem 2016, 38: 1055–1062.

    38. Yang JM, Meng X, Xue F, et al. ACE2 in the context of 2019-nCoV infection: friend or foe? Zhonghua Xin Xue Guan Bing Za Zhi 2020, 48: E12. (Chinese)

    39. Batlle D, Wysocki J, Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci 2020, 134: 543–545.

    40. Diaz JH. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med 2020.

    41. Lu Y, Wang B, Shi Q, et al. Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells. Sci Rep 2016, 6: 39123.

    42. Wilkins SE, Abboud MI, Hancock RL, et al. Targeting protein-protein interactions in the HIF system. ChemMedChem 2016, 11: 773–786.

    43. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003, 9: 677–684.

    44. Harikrishnan H, Jantan I, Haque MA, et al. Anti-inflammatory effects ofSchum. & Thonn. through inhibition of NF-kappaB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages. BMC Complement Med Ther 2018, 18: 224.

    45. Dai J, Gu L, Su Y, et al. Inhibition of curcumin on influenza a virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-kappaB pathways. Int Immunopharmacol 2018, 54: 177–187.

    46. Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-kappaB signaling pathway. Influenza Other Respir Viruses 2017, 11: 457–463.

    47. Ju M, Liu B, He H, et al. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-kappaB pathway. Cell Cycle 2018, 17: 2001–2018.

    48. Yang H, Zhuo J, Sun C, et al. Pogostone attenuates TNF-alpha-induced injury in A549 cells via inhibiting NF-kappaB and activating Nrf2 pathways. Int Immunopharmacol 2018, 62: 15–22.

    49. Jiang K, Guo S, Yang C, et al. Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-kappaB pathway. Int Immunopharmacol, 2018, 64: 140–150.

    :

    Yu-Liang Zhang analyzed most of the data from database, and wrote the initial draft of the paper; Guo-Wei Zhang developed the idea for the study; Qian Cui and Dou Zhang conducted the enrichment analyses; all authors analyzed the data and discussed the results and revised the manuscript.

    :

    This study was supported by the Foundation of Health Commission of Hebei Province (20190123) and the Natural Science Foundation of Hebei Province of China (H2018201179).

    :

    XBJ, Xuebijing; COVID-19, coronavirus disease 2019; TCM, traditional Chinese medcine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology; I-T-G-K, ingredients-targets-GO-KEGG; BC, betweenness centrality; CC, closeness centrality; IL, interleukin; AKT1, protein kinase 1; HIF-1, hypoxia inducible factor-1; BCL2, B-cell lymphoma-2; ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; PDB, Protein Data Bank.

    :

    The authors declare no conflicts of interest.

    :

    Yu-Liang Zhang, Qian Cui, Dou Zhang, et al. Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology. Traditional Medicine Research 2020, 5 (4): 201–215.

    :Rui-Wang Zhao.

    :06 April 2020,

    20 April 2020,

    : 18 May 2020.

    Guo-Wei Zhang. No.342, Yuhua Dong Road, College of Traditional Chinese Medicine, Hebei University, Baoding 071000, China. E-mail: xxzgw@126.com.

    10.12032/TMR20200507178

    熟妇人妻不卡中文字幕| 久久热精品热| 国产亚洲精品久久久com| √禁漫天堂资源中文www| 全区人妻精品视频| 乱系列少妇在线播放| 在线观看av片永久免费下载| 久久久午夜欧美精品| 国内少妇人妻偷人精品xxx网站| 男女免费视频国产| 插逼视频在线观看| 久久99精品国语久久久| av福利片在线| 日韩伦理黄色片| 国产极品粉嫩免费观看在线 | 99九九在线精品视频 | 久久久久久久久久成人| 国产成人91sexporn| h日本视频在线播放| 搡老乐熟女国产| 18禁在线播放成人免费| 中文字幕久久专区| 一本色道久久久久久精品综合| 亚洲国产成人一精品久久久| 欧美精品人与动牲交sv欧美| 欧美 亚洲 国产 日韩一| 最黄视频免费看| 欧美日韩综合久久久久久| 熟妇人妻不卡中文字幕| 欧美激情极品国产一区二区三区 | 久久精品国产亚洲av涩爱| 嫩草影院新地址| 免费高清在线观看视频在线观看| 中文字幕久久专区| 丰满迷人的少妇在线观看| 午夜日本视频在线| 人妻一区二区av| 国产精品99久久99久久久不卡 | 人妻夜夜爽99麻豆av| 久久99一区二区三区| 亚洲丝袜综合中文字幕| 国产在线男女| 欧美+日韩+精品| 国产伦在线观看视频一区| 一个人看视频在线观看www免费| 欧美日本中文国产一区发布| 91久久精品电影网| 纵有疾风起免费观看全集完整版| av在线app专区| 久久毛片免费看一区二区三区| 日韩欧美一区视频在线观看 | 青春草国产在线视频| 男人爽女人下面视频在线观看| 插阴视频在线观看视频| 99热6这里只有精品| 国产91av在线免费观看| 欧美老熟妇乱子伦牲交| 亚洲性久久影院| 国产成人精品福利久久| 国产av一区二区精品久久| 91成人精品电影| 精品卡一卡二卡四卡免费| 最近中文字幕高清免费大全6| 成人影院久久| 日本色播在线视频| 亚洲欧美日韩东京热| 99热这里只有精品一区| 91精品国产国语对白视频| 日韩制服骚丝袜av| 永久免费av网站大全| 亚洲精品一二三| 老熟女久久久| 最近的中文字幕免费完整| av卡一久久| av一本久久久久| 日本av免费视频播放| av网站免费在线观看视频| 日韩中字成人| 欧美少妇被猛烈插入视频| 人人妻人人添人人爽欧美一区卜| 男女国产视频网站| 国产精品久久久久成人av| 性色av一级| 乱码一卡2卡4卡精品| 晚上一个人看的免费电影| 一级毛片我不卡| 久久人人爽人人片av| 乱人伦中国视频| 人妻 亚洲 视频| 人人妻人人看人人澡| 丰满人妻一区二区三区视频av| 久久亚洲国产成人精品v| 超碰97精品在线观看| 一本大道久久a久久精品| 一级二级三级毛片免费看| 婷婷色综合大香蕉| 三级国产精品欧美在线观看| 中文资源天堂在线| 国产av一区二区精品久久| 亚洲图色成人| 99九九在线精品视频 | 亚洲精品,欧美精品| 18禁动态无遮挡网站| 亚洲欧美中文字幕日韩二区| 97在线视频观看| 亚洲熟女精品中文字幕| 一级毛片黄色毛片免费观看视频| 精品视频人人做人人爽| 免费看日本二区| 国产精品女同一区二区软件| 国产成人免费观看mmmm| 日韩人妻高清精品专区| 日韩,欧美,国产一区二区三区| 最近的中文字幕免费完整| 久久影院123| 亚洲av福利一区| 欧美精品国产亚洲| 桃花免费在线播放| 一区二区三区精品91| 精品亚洲成国产av| 国产精品久久久久久精品电影小说| 亚洲av电影在线观看一区二区三区| 欧美国产精品一级二级三级 | 两个人免费观看高清视频 | 高清欧美精品videossex| 最近中文字幕高清免费大全6| 少妇人妻久久综合中文| 日日啪夜夜撸| 亚洲精品亚洲一区二区| 一级毛片黄色毛片免费观看视频| 制服丝袜香蕉在线| 亚洲av中文av极速乱| 男女免费视频国产| 亚洲欧美成人精品一区二区| 国产 精品1| 欧美成人精品欧美一级黄| 亚洲精品国产av成人精品| 欧美xxxx性猛交bbbb| 黄色视频在线播放观看不卡| 天美传媒精品一区二区| 偷拍熟女少妇极品色| 久久久久人妻精品一区果冻| 免费大片黄手机在线观看| 性色av一级| 国产精品久久久久久精品电影小说| 久久青草综合色| 十分钟在线观看高清视频www| 香蕉国产在线看| 欧美激情高清一区二区三区| 亚洲精品美女久久av网站| 人人妻,人人澡人人爽秒播| 涩涩av久久男人的天堂| 欧美成人午夜精品| 黑人操中国人逼视频| 精品久久蜜臀av无| 嫁个100分男人电影在线观看| 欧美激情极品国产一区二区三区| 人人妻,人人澡人人爽秒播| 老司机靠b影院| 97精品久久久久久久久久精品| 黑人巨大精品欧美一区二区mp4| 美女国产高潮福利片在线看| 黄色毛片三级朝国网站| 亚洲少妇的诱惑av| av天堂在线播放| avwww免费| 国产一区二区三区综合在线观看| 日韩,欧美,国产一区二区三区| 性色av乱码一区二区三区2| 日韩人妻精品一区2区三区| 精品国产乱码久久久久久小说| 老鸭窝网址在线观看| 亚洲精品自拍成人| 黄色片一级片一级黄色片| www.精华液| 色视频在线一区二区三区| 人妻人人澡人人爽人人| 欧美精品亚洲一区二区| 精品国产超薄肉色丝袜足j| 日韩一区二区三区影片| 女人被躁到高潮嗷嗷叫费观| 国产精品国产三级国产专区5o| 动漫黄色视频在线观看| 老熟女久久久| 人人妻,人人澡人人爽秒播| 午夜福利乱码中文字幕| 99久久人妻综合| 国产真人三级小视频在线观看| 亚洲第一av免费看| 欧美老熟妇乱子伦牲交| 捣出白浆h1v1| 91av网站免费观看| 亚洲九九香蕉| 黄色视频不卡| 亚洲久久久国产精品| 国产亚洲一区二区精品| 激情视频va一区二区三区| 岛国在线观看网站| 99九九在线精品视频| 亚洲自偷自拍图片 自拍| 欧美人与性动交α欧美软件| 免费日韩欧美在线观看| 午夜日韩欧美国产| 老司机影院成人| 免费在线观看视频国产中文字幕亚洲 | 最新在线观看一区二区三区| 久久精品国产综合久久久| 午夜视频精品福利| 人人妻人人爽人人添夜夜欢视频| 欧美日韩成人在线一区二区| 日本av手机在线免费观看| 色老头精品视频在线观看| 在线亚洲精品国产二区图片欧美| 日韩熟女老妇一区二区性免费视频| 美女主播在线视频| 窝窝影院91人妻| 欧美 日韩 精品 国产| 久久av网站| 欧美精品人与动牲交sv欧美| 亚洲黑人精品在线| 亚洲av电影在线观看一区二区三区| www日本在线高清视频| 日本五十路高清| 欧美+亚洲+日韩+国产| 国产精品久久久人人做人人爽| 欧美精品一区二区大全| 亚洲欧洲精品一区二区精品久久久| 丝袜脚勾引网站| 午夜福利视频在线观看免费| 永久免费av网站大全| 99精国产麻豆久久婷婷| 乱人伦中国视频| 大陆偷拍与自拍| 法律面前人人平等表现在哪些方面 | 日本欧美视频一区| 一区在线观看完整版| av电影中文网址| 国产精品二区激情视频| 国产亚洲午夜精品一区二区久久| 每晚都被弄得嗷嗷叫到高潮| 这个男人来自地球电影免费观看| 亚洲欧美清纯卡通| 在线精品无人区一区二区三| 中文字幕最新亚洲高清| 天天影视国产精品| 国产97色在线日韩免费| 另类精品久久| av超薄肉色丝袜交足视频| 欧美日韩国产mv在线观看视频| 一本一本久久a久久精品综合妖精| 国产男人的电影天堂91| 精品亚洲乱码少妇综合久久| 午夜精品久久久久久毛片777| 国产精品1区2区在线观看. | 天天影视国产精品| 三级毛片av免费| 亚洲成人免费电影在线观看| 欧美精品一区二区大全| av不卡在线播放| 99精品欧美一区二区三区四区| 一级片'在线观看视频| 狠狠精品人妻久久久久久综合| 电影成人av| 亚洲欧美清纯卡通| 99精国产麻豆久久婷婷| 国产99久久九九免费精品| 久久精品国产亚洲av香蕉五月 | 亚洲色图 男人天堂 中文字幕| 一本大道久久a久久精品| www.999成人在线观看| 午夜成年电影在线免费观看| 午夜影院在线不卡| 在线天堂中文资源库| 欧美黄色淫秽网站| 久久人人97超碰香蕉20202| 亚洲国产欧美一区二区综合| 热99国产精品久久久久久7| 黄色视频不卡| 脱女人内裤的视频| 十八禁网站网址无遮挡| 91老司机精品| 亚洲男人天堂网一区| 自拍欧美九色日韩亚洲蝌蚪91| 欧美+亚洲+日韩+国产| 国产色视频综合| 欧美精品亚洲一区二区| 亚洲av欧美aⅴ国产| 黑人操中国人逼视频| 国产一区二区三区综合在线观看| 国产成人av激情在线播放| 考比视频在线观看| 国产精品 欧美亚洲| videos熟女内射| 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲精品国产区一区二| 制服诱惑二区| 国产精品久久久久久精品古装| 美女大奶头黄色视频| 我要看黄色一级片免费的| 人人妻人人澡人人爽人人夜夜| 精品第一国产精品| 91麻豆精品激情在线观看国产 | 99精品欧美一区二区三区四区| www.精华液| 国产在线观看jvid| 精品久久蜜臀av无| 免费少妇av软件| 桃花免费在线播放| 国产野战对白在线观看| 十分钟在线观看高清视频www| 91字幕亚洲| 久9热在线精品视频| 黄网站色视频无遮挡免费观看| 久久久久久久久久久久大奶| 欧美日韩av久久| 国产精品av久久久久免费| 真人做人爱边吃奶动态| videosex国产| 在线观看免费高清a一片| 美女高潮喷水抽搐中文字幕| 青春草亚洲视频在线观看| 久热这里只有精品99| 色综合欧美亚洲国产小说| 91成人精品电影| 精品国产乱码久久久久久小说| 精品国产超薄肉色丝袜足j| 亚洲一区二区三区欧美精品| 亚洲精品成人av观看孕妇| 欧美精品人与动牲交sv欧美| av免费在线观看网站| 男女之事视频高清在线观看| 又黄又粗又硬又大视频| 国产有黄有色有爽视频| 搡老熟女国产l中国老女人| 人人妻人人澡人人爽人人夜夜| 窝窝影院91人妻| 亚洲久久久国产精品| 亚洲av电影在线观看一区二区三区| 国产免费av片在线观看野外av| 午夜久久久在线观看| 精品一区二区三卡| 色综合欧美亚洲国产小说| av在线老鸭窝| 成年女人毛片免费观看观看9 | 啦啦啦视频在线资源免费观看| 亚洲国产精品999| 午夜成年电影在线免费观看| 亚洲精品久久成人aⅴ小说| 成人国语在线视频| 欧美在线黄色| 法律面前人人平等表现在哪些方面 | 精品熟女少妇八av免费久了| 飞空精品影院首页| 视频区图区小说| 欧美 日韩 精品 国产| 免费观看a级毛片全部| 一区二区三区激情视频| 中文字幕人妻丝袜制服| 精品国产国语对白av| 老司机影院毛片| 国产免费一区二区三区四区乱码| 香蕉丝袜av| 一本大道久久a久久精品| 香蕉丝袜av| 亚洲欧美清纯卡通| 大型av网站在线播放| 久久久久网色| 中国美女看黄片| 黑人巨大精品欧美一区二区mp4| 久久久久久久久久久久大奶| 国产视频一区二区在线看| 午夜福利在线观看吧| 一级黄色大片毛片| 成人手机av| 亚洲精品中文字幕在线视频| 18禁黄网站禁片午夜丰满| 黄网站色视频无遮挡免费观看| 精品免费久久久久久久清纯 | 夜夜夜夜夜久久久久| 欧美+亚洲+日韩+国产| 黄色片一级片一级黄色片| 好男人电影高清在线观看| 操出白浆在线播放| 亚洲伊人色综图| 久久这里只有精品19| 精品人妻1区二区| 国产一区二区在线观看av| 久久精品国产a三级三级三级| 视频区图区小说| 99国产极品粉嫩在线观看| 视频区图区小说| av线在线观看网站| 最新在线观看一区二区三区| 久久狼人影院| 久久午夜综合久久蜜桃| 欧美97在线视频| 一本色道久久久久久精品综合| av天堂在线播放| 成人国语在线视频| 久久精品熟女亚洲av麻豆精品| 成人三级做爰电影| 男人添女人高潮全过程视频| 一级毛片电影观看| 欧美午夜高清在线| 一级毛片女人18水好多| 在线天堂中文资源库| 午夜福利视频精品| 丝袜美腿诱惑在线| 五月天丁香电影| 永久免费av网站大全| 久热爱精品视频在线9| 色精品久久人妻99蜜桃| 国产精品一区二区精品视频观看| 伊人亚洲综合成人网| 一二三四在线观看免费中文在| a级毛片在线看网站| 日韩中文字幕欧美一区二区| 久久人妻福利社区极品人妻图片| 两性午夜刺激爽爽歪歪视频在线观看 | www.熟女人妻精品国产| 亚洲第一青青草原| 亚洲色图综合在线观看| www.av在线官网国产| 中文字幕高清在线视频| 国产免费福利视频在线观看| 亚洲欧美日韩另类电影网站| 亚洲一卡2卡3卡4卡5卡精品中文| 99久久人妻综合| 美女主播在线视频| 久久久国产欧美日韩av| 丰满人妻熟妇乱又伦精品不卡| 人妻一区二区av| 后天国语完整版免费观看| 三上悠亚av全集在线观看| 青草久久国产| 狠狠精品人妻久久久久久综合| av片东京热男人的天堂| 国产精品久久久av美女十八| 人妻久久中文字幕网| 午夜免费观看性视频| 午夜成年电影在线免费观看| 亚洲男人天堂网一区| 亚洲欧美日韩高清在线视频 | 男女床上黄色一级片免费看| 色视频在线一区二区三区| 国产在线免费精品| 国产在视频线精品| 欧美精品一区二区大全| 亚洲国产av新网站| 亚洲三区欧美一区| 午夜老司机福利片| 国产淫语在线视频| 国产人伦9x9x在线观看| 国产亚洲欧美在线一区二区| av电影中文网址| 亚洲黑人精品在线| 黄色 视频免费看| 99久久精品国产亚洲精品| 男女无遮挡免费网站观看| 丰满迷人的少妇在线观看| 亚洲精品粉嫩美女一区| 丰满少妇做爰视频| 久久99一区二区三区| 亚洲熟女毛片儿| bbb黄色大片| 天天影视国产精品| 久久人人爽av亚洲精品天堂| 中文字幕人妻丝袜一区二区| 99久久99久久久精品蜜桃| 满18在线观看网站| 建设人人有责人人尽责人人享有的| 日韩大码丰满熟妇| 久久久精品区二区三区| av片东京热男人的天堂| 他把我摸到了高潮在线观看 | 亚洲精品国产av蜜桃| 18禁裸乳无遮挡动漫免费视频| 日韩视频在线欧美| 色视频在线一区二区三区| 十八禁网站免费在线| 美女福利国产在线| 满18在线观看网站| 韩国高清视频一区二区三区| 99久久精品国产亚洲精品| 午夜免费观看性视频| 青青草视频在线视频观看| 亚洲性夜色夜夜综合| 亚洲专区字幕在线| 免费人妻精品一区二区三区视频| 国产精品影院久久| www.精华液| 日韩,欧美,国产一区二区三区| 99久久综合免费| 男女之事视频高清在线观看| 热re99久久精品国产66热6| 国产精品成人在线| 午夜免费成人在线视频| 国产成人一区二区三区免费视频网站| 成年av动漫网址| 久久久国产一区二区| 国产不卡av网站在线观看| 9色porny在线观看| 成人亚洲精品一区在线观看| 亚洲午夜精品一区,二区,三区| 一级,二级,三级黄色视频| 亚洲精品国产av蜜桃| 午夜激情久久久久久久| 亚洲av美国av| 精品国产国语对白av| av网站免费在线观看视频| 国产精品久久久久久精品古装| 成人国语在线视频| 深夜精品福利| 女人爽到高潮嗷嗷叫在线视频| 亚洲av国产av综合av卡| 精品人妻1区二区| 伦理电影免费视频| 亚洲精品美女久久久久99蜜臀| 欧美人与性动交α欧美软件| 亚洲国产精品一区二区三区在线| 啦啦啦啦在线视频资源| 夜夜夜夜夜久久久久| 18禁国产床啪视频网站| 一本综合久久免费| 成人手机av| 少妇精品久久久久久久| 久久国产精品人妻蜜桃| 国产精品自产拍在线观看55亚洲 | 大片免费播放器 马上看| 亚洲国产精品一区二区三区在线| 国产精品久久久久久精品古装| 各种免费的搞黄视频| 热99久久久久精品小说推荐| 国产成人精品久久二区二区免费| 日韩人妻精品一区2区三区| 中文字幕制服av| 十分钟在线观看高清视频www| 久久天堂一区二区三区四区| 国产成人免费无遮挡视频| 亚洲黑人精品在线| 久久久久久久国产电影| 色综合欧美亚洲国产小说| 在线天堂中文资源库| 在线十欧美十亚洲十日本专区| 免费观看a级毛片全部| 搡老岳熟女国产| 久久ye,这里只有精品| 国产一区二区三区在线臀色熟女 | 欧美日韩视频精品一区| 精品人妻一区二区三区麻豆| 欧美少妇被猛烈插入视频| 亚洲av日韩精品久久久久久密| 免费日韩欧美在线观看| 久久久国产成人免费| 成年动漫av网址| 精品第一国产精品| 欧美xxⅹ黑人| 免费在线观看影片大全网站| 婷婷丁香在线五月| 日本精品一区二区三区蜜桃| 不卡av一区二区三区| 十八禁人妻一区二区| 国产亚洲精品第一综合不卡| 亚洲精品国产一区二区精华液| 一二三四社区在线视频社区8| 美国免费a级毛片| 亚洲色图 男人天堂 中文字幕| 国产精品麻豆人妻色哟哟久久| 脱女人内裤的视频| 最近最新免费中文字幕在线| 国产日韩欧美亚洲二区| 亚洲欧洲精品一区二区精品久久久| 性高湖久久久久久久久免费观看| 亚洲精品成人av观看孕妇| 欧美黄色淫秽网站| 国产在线视频一区二区| 一边摸一边抽搐一进一出视频| 精品熟女少妇八av免费久了| 另类亚洲欧美激情| 人妻人人澡人人爽人人| 亚洲天堂av无毛| 精品视频人人做人人爽| 一区二区三区四区激情视频| 满18在线观看网站| 久久久久久久国产电影| 男女国产视频网站| 丝袜美腿诱惑在线| 性色av一级| 精品欧美一区二区三区在线| 欧美激情极品国产一区二区三区| 九色亚洲精品在线播放| 欧美人与性动交α欧美精品济南到| 99国产极品粉嫩在线观看| 正在播放国产对白刺激| 黑丝袜美女国产一区| 秋霞在线观看毛片| 两性夫妻黄色片| 男女无遮挡免费网站观看| 美女福利国产在线| 免费高清在线观看视频在线观看| 免费少妇av软件| 啦啦啦视频在线资源免费观看| 亚洲精品久久久久久婷婷小说| 久久久国产欧美日韩av| 免费在线观看日本一区| 99国产精品一区二区蜜桃av | 97人妻天天添夜夜摸| 亚洲天堂av无毛| 人妻 亚洲 视频| 91九色精品人成在线观看| 一区二区三区精品91| 美女午夜性视频免费| 99久久综合免费| 成人手机av| 成年动漫av网址|